Related Experiment Video
Updated: Jun 9, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Delay in Diagnosis of Classical Homocystinuria
Subadra Wanninayake1, Reena Sharma2,3, Diane Green4
1Department of Inherited Metabolic Disorders Queen Elizabeth Hospital Birmingham Birmingham UK.
Insights
Classical homocystinuria (HCU), a methionine metabolism disorder, often presents with delayed diagnosis. Lens subluxation is a common initial symptom in adults, highlighting the need for early recognition and expanded screening.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Classical homocystinuria (HCU) is an inherited metabolic disorder affecting methionine metabolism.
- It presents with variable clinical severity and can lead to significant complications if not diagnosed promptly.
Purpose of the Study:
- To investigate the initial clinical manifestations and diagnostic timelines in adult patients with HCU.
- To identify factors contributing to delayed diagnosis and associated complications.
Main Methods:
- Retrospective cross-sectional study involving 59 adult HCU patients from two UK tertiary referral centers.
- Analysis of clinical data, focusing on first presentation, time to diagnosis, and complications.
Main Results:
- 27.8% of patients experienced a median diagnostic delay of 7 years.
- Lens subluxation (40%) was the most frequent initial symptom in the delayed diagnosis group, followed by venous thromboembolism (33.3%).
- 32.6% of diagnosed patients had multiple complications at the time of diagnosis.
Conclusions:
- Lens subluxation is a key indicator for delayed HCU diagnosis in adults.
- Timely diagnosis through early recognition, expanded newborn screening, and increased clinician awareness is crucial for improved patient outcomes.
Abstract:
Classical homocystinuria (HCU) is an autosomal recessive disorder of methionine metabolism with a wide spectrum of severity and clinical presentation. Timely diagnosis facilitates prompt initiation of treatment, which reduces complications. Our aim was to identify the nature of the first clinical manifestation and time to subsequent diagnosis in our cohort of adults with HCU. This retrospective cross-sectional study was conducted in two tertiary referral centres for adult inherited metabolic disorders in the United Kingdom. Fifty-nine patients with sufficient clinical data for detailed analysis were included. 13/59 patients were detected asymptomatically through newborn or family screening and 46/59 were diagnosed on initial presentation with a clinical manifestation of HCU. For 15/54 (27.8%), the median time between initial presentation and diagnosis was 7 years (IQR, 2-11.9), the commonest first manifestation in the delayed group was lens subluxation (6/15, 40%) followed by venous thromboembolism (5/15, 33.3%) and skeletal deformities (2/15, 13.3%). 15/46 (32.6%) had two or more complications by the time of diagnosis. Lens subluxation is the commonest first manifestation of HCU in the group with delayed diagnosis. Early recognition, expanded screening and enhanced clinician awareness are essential for timely diagnosis and improved outcomes.
Related Concept Videos
Huntington Disease l: Introduction
Inborn Errors of Metabolism
Urine Studies II: Urine Culture and Sensitivity Test
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

